v3.26.1
Stockholders' Equity
6 Months Ended
Jun. 30, 2026
Stockholders' Equity  
Stockholders' Equity

(10)  Stockholders’ Equity

In November 2023, the Company filed an automatic shelf registration statement with the SEC to register for sale any combination of the types of securities described in the shelf registration statement, including shares of its common stock.

On February 26, 2024, the Company entered into a controlled equity offering sales agreement (“ATM Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) to allow the Company to issue and sell shares of its common stock from time to time through Cantor, acting as agent. At June 30, 2026, the Company had registered $300.0 million of its common stock to be sold pursuant to the Company’s ATM Agreement, all of which remained unsold as of that date.

In April 2026, the Company issued 11,896,750 shares of its common stock in an underwritten public offering resulting in net proceeds to the Company of $323.8 million, after deducting underwriting fees and offering expenses.

The changes in Stockholders’ Equity during the three and six months ended June 30, 2026 and 2025 are summarized below:

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Accumulated

  ​ ​ ​

  ​ ​ ​

Common

Common

Additional

Other

Total

Stock

Stock Par

Paid-In

Comprehensive

Accumulated

Stockholders’

  ​ ​ ​

Shares

  ​ ​ ​

Value

  ​ ​ ​

Capital

  ​ ​ ​

Income

  ​ ​ ​

Deficit

  ​ ​ ​

Equity

(In thousands, except share amounts)

Consolidated balance at December 31, 2025

 

66,549,442

$

67

$

2,337,453

$

3,626

$

(1,813,981)

$

527,165

Shares issued under stock option and employee stock purchase plans

 

19,529

327

327

Stock-based compensation

 

8,523

8,523

Unrealized loss on marketable securities

 

(1,104)

(1,104)

Net loss

 

(78,685)

(78,685)

Consolidated balance at March 31, 2026

 

66,568,971

$

67

$

2,346,303

$

2,522

$

(1,892,666)

$

456,226

Shares issued under stock option and employee stock purchase plans

34,452

825

825

Shares issued in underwritten offering, net

11,896,750

12

323,820

323,832

Stock-based compensation

8,408

8,408

Unrealized loss on marketable securities

(1,224)

(1,224)

Net loss

(73,503)

(73,503)

Consolidated balance at June 30, 2026

78,500,173

$

79

$

2,679,356

$

1,298

$

(1,966,169)

$

714,564

Accumulated

Common

Common

Additional

Other

Total

Stock

Stock Par

Paid-In

Comprehensive

Accumulated

Stockholders’

  ​ ​ ​

Shares

  ​ ​ ​

Value

  ​ ​ ​

Capital

  ​ ​ ​

 Income

  ​ ​ ​

Deficit

  ​ ​ ​

 Equity

(In thousands, except share amounts)

Consolidated balance at December 31, 2024

 

66,374,549

 

$

66

 

$

2,298,849

 

$

3,314

 

$

(1,555,224)

 

$

747,005

Shares issued under stock option and employee stock purchase plans

 

9,642

 

 

 

 

202

 

 

 

 

 

 

202

Stock-based compensation

 

 

 

 

 

9,316

 

 

 

 

 

 

9,316

Unrealized gain on marketable securities

 

 

 

 

 

 

 

254

 

 

 

 

254

Net loss

 

 

 

 

 

 

 

 

 

(53,796)

 

(53,796)

Consolidated balance at March 31, 2025

 

66,384,191

$

66

$

2,308,367

$

3,568

$

(1,609,020)

$

702,981

Shares issued under stock option and employee stock purchase plans

10,050

63

63

Stock-based compensation

9,191

9,191

Unrealized loss on marketable securities

(229)

(229)

Net loss

(56,600)

(56,600)

Consolidated balance at June 30, 2025

66,394,241

$

66

$

2,317,621

$

3,339

$

(1,665,620)

$

655,406